Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

Astra Zeneca's Covid-19 vaccine Vaxzevria is being withdrawn worldwide

AstraZeneca initiates a worldwide withdrawal of its Covid vaccine Vaxzevria. The measure is taken just months after the company admitted the vaccine can cause a...

Startskott för Leqembi i EU – lansering inleds i Österrike

Idag, måndag, inleds lanseringen i EU av svenskutvecklade Alzheimerläkemedlet Leqembi. Först ut är Österrike, följt av Tyskland.

Reccan i stort EU-projekt för tidig upptäckt av pankreascancer

Ett svenskt blodtest som utvecklas för tidig upptäckt av bukspottkörtelcancer spelar en viktig roll i ett stort, nystartat EU-projekt.

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Assignment: Facilitate the retention of foreign researchers

A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS 2025 in Copenhagen.

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Investigations against AstraZeneca: ”Chinese interests may be behind them”

Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.

Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

Superconductor technology: Contactless working in the laboratory of the future

Automated filling and weighing of freeze-dry containers in the cleanroom with SupraMotion from Festo

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Astra Zenecas miljövänligare inhalator närmar sig EU-godkännande

Astra Zeneca rekommenderas få godkännande i EU för sitt inhalatorläkemedel Trixeo Aerosphere som för första gången använder en ny drivgas som uppges minska milj...

Gothenburg, the city of life science – We are ‘Little Boston’

Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...

Nya hiv-läkemedlet godkänt i EU – ”Mest kraftfulla verktyget hittills”

EU-kommissionen har nu gett marknadsgodkännande åt en ny behandling, lenacapavir, som ska ge effektivt skydd mot hiv-infektion.

ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.

Lillys alzheimerläkemedel donanemab får positivt utlåtande i EU

Efter flera olika turer har nu Eli Lillys läkemedel donanemab rekommenderats för godkännande i EU för behandling av tidig symtomatisk Alzheimers sjukdom.

Klartecken i EU för ny behandling av blodcancer

EU-kommissionen har godkänt GSK:s läkemedel Blenrep för behandling av vuxna med återkommande eller behandlingsresistenta former av multipelt myelom.

Ingrid Lönnstedt: What does the p-value mean?

The smaller the better, and preferably smaller than 0.05. A p-value smaller than 5% means that the treatment effect is statistically significant at 5% significa...

Achieve Effortless, Standardized Automation with the new ZEISS Automation Interface

Simple interfaces for automated loading of CMMs.

A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024

The new year brings new features for the readers of Life Science Sweden.

Lonza